产品详情
Targets
Target | Value |
---|---|
EGFR | IC50: 38.5nM |
Src | IC50: 282nM |
MEK/ERK | IC50: 800nM |
ErbB2 | IC50: 1.255μM |
Raf | IC50: 3.353μM |
c-Met | IC50: 4.1μM |
CDK4 | IC50: >20μM |
In vitro | DMSO | 12 mg/mL (25.64 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 21.37 mL | 106.86 mL | 213.72 mL |
0.5 mM | 4.27 mL | 21.37 mL | 42.74 mL |
1 mM | 2.14 mL | 10.69 mL | 21.37 mL |
5 mM | 0.43 mL | 2.14 mL | 4.27 mL |
*The above data is based on the productmolecular weight 467.9 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10706 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 467.9 |
Formula | C24H23ClFN5O2 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 257933-82-7 |
Synonyms | WAY-EKB 569 |
SMILES | CCOC1=C(C=C2C(=C1)N=CC(=C2NC3=CC(=C(C=C3)F)Cl)C#N)NC(=O)/C=C/CN(C)C |
产品标签
Product Questions
Product Questions
BIBW2992 (Afatinib)
BIBW2992 (Afatinib)是酪氨酸激酶抑制剂(TKI),它不可逆地抑制人表皮生长因子受体2(Her2)和表皮生长因子…
AG-18 (Tyrphostin 23)
AG-18 (Tyrphostin 23)是人表皮癌细胞系A431中的表皮生长因子(EGF)受体激酶抑制剂,IC50值为35M。
ARRY-543 (Varlitinib, ASLAN001)
ARRY-543 (Varlitinib,ASLAN001)是一种新型口服ErbB家族抑制剂,与批准的ErbB抑制剂不同,它直接或间接靶向ErbB家…
Neratinib (HKI-272)
Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
ASP8273 (Naquotinib)
ASP8273 (Naquotinib)是不可逆的,第三代,选择性突变的表皮生长因子受体(EGFR)抑制剂,具有潜在的抗肿瘤…